5-fluorodihydrouracil has been researched along with edoxudin in 1 studies
Studies (5-fluorodihydrouracil) | Trials (5-fluorodihydrouracil) | Recent Studies (post-2010) (5-fluorodihydrouracil) | Studies (edoxudin) | Trials (edoxudin) | Recent Studies (post-2010) (edoxudin) |
---|---|---|---|---|---|
44 | 3 | 6 | 72 | 1 | 10 |
Protein | Taxonomy | 5-fluorodihydrouracil (IC50) | edoxudin (IC50) |
---|---|---|---|
Thymidine kinase | Macacine alphaherpesvirus 1 | 0.15 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erdélyi-Tóth, V; Jeney, A; Katona, C; Kovács, P; Kralovánszky, J; Noordhuis, P; Otvös, L; Pandi, E; Peters, GJ; Van der Wilt, CL | 1 |
1 other study(ies) available for 5-fluorodihydrouracil and edoxudin
Article | Year |
---|---|
5-ethyl-2'-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Colonic Neoplasms; Deoxyuridine; Dose-Response Relationship, Drug; Drug Synergism; Fluorodeoxyuridylate; Fluorouracil; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Time Factors; Treatment Outcome; Uracil; Uridine | 1999 |